Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy-Reference-Cited by-同舟云学术

Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy

Published:2019-07-09 Issue:10 Volume:24 Page:1182-1189
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Kibe Yuichi,Nakamura Naoki,Kuno Hirofumi,Hiyama Takashi,Hayashi Ryuichi,Zenda Sadamoto,Motegi Atsushi,Hojo Hidehiro,Nakamura Masaki,Ariji Takaki,Oyoshi Hajime,Akimoto Tetsuo

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-019-01479-x.pdf

Reference10 articles.

1. Adelstein D, Gillison ML, Pfister DG et al (2017) NCCN guidelines insights: head and neck cancers, version 2.2017. J Natl Compr Canc Netw 15(6):761–770. https://doi.org/10.6004/jnccn.2017.0101

2. Bernier J, Domenge C, Ozsahin M et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19):1945–1952. https://doi.org/10.1056/NEJMoa032641

3. Cooper JS, Pajak TF, Forastiere AA et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350(19):1937–1944. https://doi.org/10.1056/NEJMoa032646

4. Bernier J, Cooper JS, Pajak TF et al (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27(10):843–850. https://doi.org/10.1002/hed.20279

5. Dutta PR, Riaz N, McBride S et al (2016) Postoperative PET/CT and target delineation before adjuvant radiotherapy in patients with oral cavity squamous cell carcinoma. Head Neck 38(Suppl 1):E1285–1293. https://doi.org/10.1002/hed.24213

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction chemotherapy with paclitaxel, carboplatin, and cetuximab (PCE) followed by chemoradiotherapy for unresectable locoregional recurrence after curative surgery in patients with squamous cell carcinoma of the head and neck;Frontiers in Oncology;2024-07-01

2. The impact of national holidays on postoperative radiotherapy of squamous cell carcinoma of the head and neck;Clinical and Translational Radiation Oncology;2023-09

3. Survival benefit associated with postoperative PET–CT before adjuvant radiotherapy or chemoradiotherapy in patients with oral squamous cell carcinoma;International Journal of Oral and Maxillofacial Surgery;2022-11

4. Rapid clinical progression of stage III-IV oral and oropharyngeal cancer after upfront surgery and difficulty in the assessment of the effectiveness of adjuvant radiotherapy;Head and Neck Tumors (HNT);2022-08-01

5. Prognostic importance of DNA from human papillomavirus in patients with oral squamous cell carcinoma;Medicina Oral Patología Oral y Cirugia Bucal;2022